| ATPC 0.1125 60.71% | MTEN 0.032 -9.35% | OCG 0.0101 -14.41% | SOXS 2.105 -7.68% | AUID 1.8301 84.39% | CJMB 3.3967 203.28% | IVP 0.0532 -35.12% | ZSL 2.87 1.95% | NVDA 188.6 2.98% | SLV 84.07 -0.58% | ASST 0.9832 -4.54% | INTC 48.835 0.24% | SPHL 15.395 584.22% | DVLT 0.7302 1.67% | BBAI 6.45 3.04% | TZA 5.935 -3.65% | GRAB 4.355 -5.94% | TQQQ 54.815 1.83% | BYND 1.045 8.64% | BNKK 4.2269 52.05% | SOXL 59.9614 8.27% | ONDS 13.51 -0.37% | APLT 0.1009 1.00% | IBRX 3.8945 28.96% | NVD 6.9723 -5.91% | DNN 3.565 2.15% | BITO 13.245 -2.32% | DUST 5.72 -1.29% | AAL 15.685 3.60% | PLUG 2.31 -1.70% | TSLS 5.175 -0.29% | TSLL 18.1599 0.50% | PTHL 0.962 118.74% | EEM 58.18 0.74% | SPY 693.39 0.44% | MSTX 4.88 -6.15% | FNGD 5.465 -0.82% | SIDU 3.78 0.80% | AMD 233.32 4.35% | IBIT 54.14 -2.34% | NOK 6.6358 4.34% | ACHR 9.0999 2.13% | JDST 2.069 -1.71% | RZLV 4.715 16.13% | QQQ 623.35 0.61% | GPUS 0.2905 -9.47% | XLE 47.6476 -0.86% | TSLA 440.4 0.27% | VALE 14.735 0.86% | SNAP 7.775 -1.58%

Owens & Minor Sinks 34% After Q2 Miss And Segment Divestiture Plans

Owens & Minor (NYSE:OMI) shares tumbled 34% on Monday after posting second-quarter earnings below expectations and announcing plans to divest its Products & Healthcare Services segment.

Adjusted earnings from continuing operations were $0.26 per share, missing the $0.29 consensus. Revenue from continuing operations, mainly from the Patient Direct segment, rose 3.3% year-over-year to $681.9 million.

CEO Ed Pesicka said the company is in the final stages of selling the Products & Healthcare Services business and will operate as a focused Patient Direct company going forward.

Adjusted EBITDA from continuing operations increased to $96.6 million from $91.1 million a year earlier.

Published on: August 11, 2025